Lectures and seminars SRP Diabetes Seminar: “Targeting mitochondria to treat MASLD/MASH, obesity and cardiometabolic disease”
Join us in a seminar by Prof. Gerald I. Shulman, from Yale University, in which he will discuss his latest work on targeting mitochondria as a therapeutic strategy to address liver steatosis and associated cardiometabolic disease.
Dr. Shulman is the George R. Cowgill Professor of Medicine and Cellular & Molecular Physiology at Yale. He is also an Investigator Emeritus of the Howard Hughes Medical Institute and Co-Director of the Yale Diabetes Research Center. Dr. Shulman has pioneered the use of magnetic resonance spectroscopy combined with mass spectrometry to non-invasively examine intracellular glucose and fat metabolism in humans and transgenic rodent models that have led to several paradigm shifts in our understanding of type 2 diabetes (T2D), including the molecular mechanisms by which ectopic lipid promotes liver and muscle insulin resistance, as well as developing new drugs for the treatment of T2D, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Title: "Targeting mitochondria to treat MASLD/MASH, obesity and cardiometabolic disease"
Date: 30th October 2026
Time: 14:00 (Fika will be served afterwards)
Location: Eva & Georg Klein Lecture hall